Vertex Pharmaceuticals Inc (NQ: VRTX)
66.18 USD  -0.74 (-1.11%)
Official Closing Price  /  Updated: 8:10 PM EDT, Apr 24, 2014  /  Add to My Watchlist      
(VRTX) Community Analysis from
April 24, 2014
(Jutia Group, 11/4/13)
[at Motley Fool] - Gilead Sciences and Johnson & Johnson are about to launch new oral hepatitis C treatments that will significantly reduce Vertex sales from Incivek. The company hopes...(read more)
(Jutia Group, 11/4/13)
[at Motley Fool] - Gilead Sciences and Johnson & Johnson are about to launch new oral hepatitis C treatments that will significantly reduce Vertex sales from...(read more)
(Stock Blog Hub, 4/27/13)
Actelion Ltd. (ALIOF) reported first quarter 2013 earnings of $1.35 per American Depository Receipt (ADR), up 56.1% from the prior-year earnings of 87 cents per ADR. Earnings were well...(read more)
Vertex Pharmaceuticals (VRTX) Company Overview

There is no analysis for VRTX yet. But you can go to Wikinvest to help create one!


Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here